Alembic Ltd


BSE: 506235 | NSE: ALEMBICLTD | ISIN: INE426A01027 
Market Cap: [Rs.Cr.] 272 | Face Value: [Rs.] 2
Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

 Discuss this stock

Board Meet

24-Apr-13 
Alembic Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on April 24, 2013, inter alia, to transact following business: 1. To consider and approve Audited Financial statements of the Company for the Financial year ended March 31, 2013. 2. To consider and recommend dividend, if any, for the Financial Year ended March 31, 2013. Alembic Ltd has informed BSE that the Board of Directors of the Company at its meeting held on April 24, 2013, inter alia, have taken the following decisions: 1. The Board has recommended a dividend of Re. 0.20 (10%) per Equity Share of Rs. 2 each, subject to approval of Shareholders at the Annual General Meeting. 2. The Board has appointed Mr. Udit Amin as Additional Director and Director & President-Real Estate Business w.e.f. April 24, 2013. Further Mr. Udit Amin has been designated as CEO of the Company w.e.f. April 24, 2013. 3. Mr. Ashok Tulankar has resigned as Manager of the Company w.e.f. April 30, 2013, however, he shall continue as Non-Executive Director of the Company. (As per BSE Announcement Dated on 24.04.2013) 
31-Jan-13 
Quarterly Results 
21-Jan-13 
Quarterly Results 
08-Nov-12 
Quarterly Results 
13-Aug-12 
Quarterly Results 

AGM

13-Aug-12
Alembic Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from August 06, 2012 to August 13, 2012 (both days inclusive) for the purpose of 105th Annual General Meeting (AGM) of the Company to be held on August 13, 2012. Alembic Ltd has informed BSE that the Annual General Meeting (AGM) of the Company was held on August 13, 2012. ( As Per BSE Announcement Dated on 17.08.2012) 
29-Aug-11
Alembic Ltd has informed BSE that the members at the 104th Annual General Meeting (AGM) of the Company held on August 29, 2011, inter alia, has passed the following resolutions: 1. Approval and adoption of the Annual Accounts for the year ended March 31, 2011 together with reports of Directors and Auditors thereon. 2. Re-appointment of Mr. Chirayu Amin as Director. 3. Re-appointment of Dr. B. R. Patel as Director. 4. Appointment of K. S. Aiyar and Co., Chartered Accountants, Mumbai as statutory auditors of the Company from the conclusion of this Annual General Meeting (AGM) till conclusion of next Annual General Meeting. 5. Appointment of Mr. R. M. Kapadia as Director, liable to retire by rotation. 6. Approval to the office or place of profit held by Mr. Sanjay Bhatt as Director and Company Secretary of the Company from March 31, 2011 to July 28, 2011. 7. Approval to the excess remuneration paid to the Whole-time Director for the year 2010-2011. 
30-Jul-10
Alembic Limited has submitted to the Exchange a copy of Notice of the Annual General Meeting of the Members of the Company to be held on July 30, 2010. Alembic Ltd has informed BSE that the members at the 103rd Annual General Meeting (AGM) of the Company held on July 30, 2010, have accorded their unanimous approval for the followings: 1. Adoption of Audited Balance Sheet and Profit & Loss Account for the year ended on March 31, 2010 and the reports of the Directors and Auditors thereon. 2. Declaration of dividend on equity shares @ 25% (i.e. Rs. 0.50/- per share). 3. Re-appointment of Mr. Paresh Saraiya & Mr. Pranav Amin as Directors of the Company, liable to retire by rotation. 4. Appointment of M/s. K. S. Aiyar & Co., Chartered Accountants as Auditors of the Company. 5. Appointment of Mr. Milin Mehta as Director of the Company, liable to retire by rotation. 6. Approval by way of a special resolution for revision in the remuneration of Mr. Pranav Amin, Director & President-International Business w.e.f. April 01, 2010. 7. Approval by way of a special resolution for revision in the remuneration of Mr. Shaunak Amin, President-Formulations w.e.f. April 01, 2010 subject to approval of Central Government. (As Per BSE Announcement Website dated on 31.07.2010) 
28-Jul-09
Alembic Limited has submitted to the Exchange a copy of Notice of the Annual General Meeting of the Shareholders of the Company to be held on July 28, 2009. Alembic Ltd has informed BSE that the members at the 102nd Annual General Meeting (AGM) of the Company held on July 28, 2009, inter alia, have accorded the following: 1. Adoption of Audited Balance sheet and Profit & Loss Account for the year ended on March 31, 2009 and the reports of the Directors and Auditors thereon. 2. Declaration of dividend on equity shares @ 20% (i.e. Rs 0.40/- per share). 3. Re-appointment of Dr. B R Patel & Mr. P N Parikh as Directors of the Company, liable to retire by rotation. 4. Appointment of M/s. K S Aiyar & Co., Chartered Accountants as Auditors of the Company. 5. Approval by way of a special resolution for the excess remuneration paid to Managerial Personnel for the year 2008-09 subject to approval of the Central Government. (As Per BSE Announcement Website dated on 29.07.2009) 
28-Jul-08
Alembic Limited has informed the Exchange that the Annual General Meeting of the members of the Company will be held on July 28, 2008. Alembic Ltd has informed BSE that the members at the 101st Annual General Meeting (AGM) of the Company held on July 28, 2008, inter alia, have accorded to the following: 1. Adoption of Audited Balance sheet and Profit & Loss Account for the year ended on March 31, 2008 and the reports of the Directors and Auditors thereon. 2. Declaration of dividend on equity shares @ 75% (i.e. Rs 1.50/- per share). 3. Re-appointment of Mr. R K Baheti & Mr. K G Ramanathan as Directors of the Company, liable to retire by rotation. 4. Appointment of M/s. K S Aiyar & Co., Chartered Accountants as Auditors of the Company. 5. Re-appointment of Mr. R K Baheti, as Director & President-Finance of the Company for further period of 5 years from January 25, 2008 and approval of his remuneration. 6. Re-appointment of Mr. Chirayu Amin, as Managing Director of the Company for further period of 5 years from May 01, 2008 and approval of his remuneration. 7. Re-appointment of Mrs. Malika Amin, as Whole-time Director of the Company for further period of 5 years from July 07, 2008 and approval of her remuneration. 8. Increase in borrowing powers of the Company pursuant to Section 293 (1)(d) of the Companies Act, 1956. (As per BSE Announcement Website dated on 29/07/2008) 

EGM

16-Sep-10
Alembic Ltd has informed BSE that by an Order made on the August 02, 2010 and further order made on August 09, 2010, in the above Company Application, the Hon'ble High Court of Gujarat at Ahmedabad has directed that a meeting of the Equity Shareholders of the Company will be held on September 16, 2010., for the purpose of considering and, if thought fit, approving with or without modification(s), the Composite Scheme of Arrangement in the nature of De-merger and Transfer of the Pharmaceutical Undertaking of Alembic Ltd to Alembic Pharma Ltd and consequential Re-organisation of Share Capital in form of utilisation of the Share Premium Account of Alembic Ltd, proposed between the Applicant Company and its Equity Shareholders. Alembic Ltd has informed BSE that pursuant to the directions issued by the Hon'ble High Court of Gujarat vide order dated August 02, 2010, the meetings of the Secured Creditors, Un-secured Creditors, Shareholders and Fixed Depositors of the Company were convened on September 16, 2010 and at the respective meetings, unanimous approval has been granted to the Composite Scheme of Arrangement in the nature of demerger and transfer of Pharmaceutical Undertaking of Alembic Ltd. to Alembic Pharma Ltd. and consequential re-organization of Share Capital in form of utilization of the Share Premium Account of Alembic Ltd. The Chairman's report in this regard is being submitted to the Hon'ble High Court of Gujarat. The said scheme is now subject to requisite approvals and sanctions, inter-alia, of the Hon'ble High Court of Gujarat. (As Per BSE Announcement Dated on 17.09.2010) 
26-Nov-04
Alembic Limited has informed the Exchange that the BoD's of the company at its meeting held on October 26, 2004 has, inter alia, approved the proposal to issue upto 1200000 Equity Shares of Rs.10/- each at a price not below the price to be determined as per the SEBI Guidelines relating to preferential issue to the promoter group subject to Shareholder's approval and other necessary permissions, if required. The approval of the members pursuant to section 81(1A) and SEBI Guidelines relating to Preferential Issue shall be taken in the EGM of the company to be held on November 26, 2004. Alembic Limited has informed the Exchange that an EGM of the members of the Company will be held on November 26, 2004 to create, offer, issue and/or allot for cash on a preferential basis upto 1200000 equity shares of Rs.10/- each in aggregate, at the rate of Rs.161/- per share (including premium of Rs.151/- per share) on such terms as may be deemed appropriate by the Board to the following persons forming part of the Promoters Group of the Company : 1) Shreno Investment & Finance Limited - 400000 equity shares; 2) Sierra Investments Limited - 400000 equity shares; 3) PSU Chemicals Private Limited - 100000 equity shares; 4) Whitefield Chemtech Private Limited - 200000 equity shares; 5) Whitefield Medicare Private Limited - 100000 equity shares (As per NSE Bulletin dated on 09/11/2004) The Company has informed that at the EGM held on 26th November, 2004 members approved the proposal to issue upto 12,00,000 Equity Shares of Rs 10 each at a price of Rs. 161/- ( including premium of Rs. 151/- per shares) to the promoter group compnies on Preferential Allotment basis. (As per BSE Bulletin dated on 29/11/2004) Alembic Limited has informed the Exchange that the members of the company at its EGM held on November 26,2004 have passed a special resolution for issuance of 12,00,000 equity shares of Rs.10/- each,in aggregate,at the rate of Rs.161/- per share(including premium of Rs.151/- per share)to promoter group companies on preferential basis in terms of SEBI(Disclosure & Investor protection ) Guidelines,2000 for preferential Allotment,as in force. (As per NSE Bulletin dated on 01/12/2004) 
12-Mar-04
EGM 12/03/2004 Bonus Issue Alembic Limited has informed the Exchange that the BoDs of the company, in its meeting held on February 12, 2004, has recommended to issue Bonus Equity Shares in the proportion of 2:1 i.e. 2 fully paid up Bonus Equity Shares of Rs.10/- each for every 1 existing fully paid equity share of Rs.10/- each held as on the record date to be announced later on. The said Bonus shares will also be issued in the said proportion on the shares to the allottees of recent Rights Issue provided the allottees pay full amount called up on or before the record date. The company has convened EGM on March 12, 2004 to approve issue of Bonus Shares in accordance with the provisions of the Companies Act, 1956 and that of the Articles of Association of the Company. (As per NSE Bulletin datedc on 12/02/2004) Alembic Limited has informed the Exchange that pursuant to the Resolution passed in the Extra-ordinary General Meeting of the Company held on March 12, 2004, the Allotment Committee duly constituted by the Board of Directors of the Company, at its meeting held on March 30, 2004, have allotted 1,76,19,742 Equity Shares of Rs. 10/- each as fully paid up Bonus Shares, on 88,09,871 fully paid up existing equity shares of Rs. 10/- each of the Company to the shareholders whose names appear in the Register of Members on the Record Date i.e. March 27, 2004. Further, the company informed that, the Bonus entitlement have been deferred on the shares issued under the rights Offer and which have not been made fully paid-up till the Record Date i.e. March 27, 2004. Bonus shares on such shares shall be allotted if they are made fully paid up on or before April 30, 2004. Total 20,579 equity shares issued under the Rights Offer are partly paid-up as on Record date i.e. March 27, 2004. (As per NSE BUlletin dated on 31/03/2004) 

Peer Comparison

Company Market Cap
(Rs. in Cr.)
P/E (TTM)
(x)
P/BV (TTM)
(x)
EV/EBIDTA
(x)
ROE
(%)
ROCE
(%)
D/E
(x)
Sun Pharma.Inds. 99,966.47 69.45 12.33 27.45 26.1 27.0 0.01
Dr Reddy's Labs 35,282.65 27.88 4.63 18.79 14.3 16.6 0.25
Cipla 34,095.15 22.27 4.52 14.11 15.9 19.8 0.03
Ranbaxy Labs. 19,947.05 0.00 10.38 72.87 0.0 0.0 2.38
Wockhardt 19,705.77 117.38 163.78 12.82 237.0 30.3 2.09
Cadila Health. 16,756.95 40.62 6.57 18.45 28.4 24.2 0.40
Glenmark Pharma. 15,498.19 40.15 6.14 23.94 12.7 11.7 0.39
Piramal Enterp. 10,037.23 0.00 0.95 23.66 0.8 2.1 0.07
Ipca Labs. 7,378.91 22.19 5.85 10.09 24.2 23.7 0.49
Torrent Pharma. 6,230.57 11.65 4.78 11.66 29.6 25.5 0.48
Biocon 5,708.00 19.90 2.59 12.20 12.6 13.6 0.08
Aurobindo Pharma 5,598.32 13.31 2.24 22.89 10.7 8.8 1.01
Strides Arcolab 5,198.17 35.44 3.79 16.20 5.1 5.7 0.97
Mylan Lab. 3,273.19 6.80 1.77 0.00 26.9 26.1 0.59
Alembic Pharma 2,470.29 15.69 5.37 5.60 39.5 27.7 1.07

Futures & Options Quote

 
Expiry Date
NA
Instrument: NA
Expiry Date: NA
Strike Price: NA
Open Price: NA
Average Price: NA
No. of Contracts Traded: NA
Open Interest: NA
Underlying: NA
Option Type: NA
Market Lot: NA
Previous Close: NA
Day’s High | Low: NA | NA
Turnover (Cr.): NA
Open Int. Change: NA | NA
View detailed F& O quotes >>

Key Information

Key Executives:

Chirayu R Amin , Chairman  

Malika C Amin , Non Executive Director  

Milin Mehta , Director  

R M Kapadia , Director  


Company Head Office / Quarters:
Alembic Road,
,
Vadodara,
Gujarat-390003
Phone : 91-0265-2280550/2280880
Fax : 91-0265-2282506
E-mail : alembic@alembic.co.in
Web : http://www.alembic-india.com
Registrars:
Link Intime India Pvt Ltd
B-102&103 Shangrila
Complex First Floor
Akota
Vadodara - 390 020

Fund Holding

 
Scheme Name No. of Shares
No data found

Calendar

May-2013
M T W T F S S
13 14 15 16 17 18 19
IPO
listIssue Open : Onesource Techm.
Economic Events
list Fed's Bernanke Delivers Commencement Speech at Bard College
Results
list No result today